Paroxysmal AF Catheter Ablation With a Contact Force Sensing Catheter

2014474 citationsJournal Articlehybrid Open Access

Authors

Andrea Natale · California Pacific Medical Center

Vivek Y. Reddy · Icahn School of Medicine at Mount Sinai

George Monir · Florida Hospital Cancer Institute

David J. Wilber

Bruce D. Lindsay · Cleveland Clinic

H. Thomas McElderry · University of Alabama at Birmingham

Charan Kantipudi · Piedmont Atlanta Hospital

Abstract

The SMART-AF trial demonstrated that this irrigated CF-sensing catheter is safe and effective for the treatment of drug refractory symptomatic PAF, with no unanticipated device-related adverse events. The increased percent of time within investigator-targeted CF ranges correlates with increased freedom from arrhythmia recurrence. Stable CF during radiofrequency application increases the likelihood of 12-month success. (THERMOCOOL® SMARTTOUCH® Catheter for Treatment of Symptomatic Paroxysmal Atrial Fibrillation; NCT01385202).

Topics & Keywords

Atrial Fibrillation Management and Outcomes Cardiac Arrhythmias and Treatments Cardiac electrophysiology and arrhythmias

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of the American College of Cardiology

Volume 64, Issue 7, pp. 647-656

DOI: 10.1016/j.jacc.2014.04.072

Field-Weighted Citation Impact: 34.52